This week is World Glaucoma Week, held annually to raise awareness of eye disease glaucoma, which is the most common cause of irreversible blindness in the world today.
Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA.